DNA Capital
VC Fund
São Paulo, Brazil
DNA Capital is an investment partnership specializing in multi-stage investments in the healthcare sector.
- Total investments:
- 43
- Last investment:
- Lead investor:
- 44%
- Fund size:
- $3.7M
- Last fund:
Last updated:
For AI agents: llms.txt
Industries DNA Capital invests in
Stages DNA Capital invests in
Countries DNA Capital invests in
Round sizes
Contacts
Round size
- Seed
- $250k–$8M
- Series A
- $2M–$30M
- Series B
- $4.6M–$30M
Investment Focus
Industry
- Health Care 23 (53%)
- Medical 13 (30%)
- Software 5 (12%)
- Health Insurance 5 (12%)
- Hospital 4 (9%)
Stage
- Seed 8 (19%)
- Series A 7 (16%)
- Series B 5 (12%)
- Series C 5 (12%)
- Venture - Series Unknown 3 (7%)
Country
- United States 13 (30%)
- Brazil 11 (26%)
- China 1 (2%)
- Senegal 1 (2%)
- Hong Kong 1 (2%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
Carlos de Barros Jorge Neto
Partner
|
Partner | Total investments: 0 | Find email | |
José Guinle
Partner
|
Partner | Total investments: 1 | Find email | |
Luiz Felipe D Martins Costa
Managing Partner
|
Managing Partner | Total investments: 0 | Find email | |
Luiz Noronha
Partner
|
Partner | Total investments: 11 | Find email | |
Mario Sergio Ribeiro
Partner
|
Partner | Total investments: 0 | Find email | |
| See all 7 team members → | ||||
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| The safest and friendliest e-prescribing tool, for doctors. The most convenient and affordable way for treatment adherence, for patients. | $15.9M / May 21, 2026 | ||
| Reema Health is a technology startup transforming how people navigate the gaps between health care and social care. They believe that a personalized, community-based approach to care makes it easy for anyone to access the things they need to make their lives better. | $7.5M / Series A / Oct 10, 2024 | ||
| Hi there, we are Piwi®. Like a broker, only easier. We didn’t create the company because we were in love with the market. It was exactly the opposite. With an easy to use and intuitive digital benefit managing platform we replaced the old school brokerage changing the way in which companies research, buy and manage their health plans and benefits.That’s evolution coming around! | $4M / Seed / Oct 01, 2022 | ||
| Sanar seeks to reshape future doctors and healthcare professionals to be much more efficient and assertive. We started the company as a knowledge platform; from the first moment they step into college, we follow the evolution of the professional throughout their career. Today, Sanar has become a platform for doctors entire lives, offering solutionsfor different stages of their journey: 1 - For students we offer SanarFlix; the platform has a multitude of content from the best teachers in the country and is helping the students to overcome the challenges they face in college. 2 - For the period of admission to medical residency, Sanar offers Sanar Medical Residency, a platform for test preparation to help doctors to enter the best programs in Brazil. 3 - For the general physician, we offer SanarYellow, a clinical decision-making tool with the most up-to-date guidelines, protocols, and drug interactions for point-of-care. 4 - Sanar is also helping to unlock the doctor's potential with SanarUp, a credit product which offers additional income for the most difficult phases of their professional career. | Debt Financing / May 25, 2022 | ||
| Inspirali is an educational institute providing post-graduate training in the health sector. Inspirali provides comprehensive essential knowledge to help individuals develop and qualify their skills so they can become doctors of the future. Inspirali collaborates with partners who share the same vision, and together they move from productdevelopment to technological innovation, always with the goal of empowering future doctors who will democratize access to health. | $180.9M / Private Equity / Apr 01, 2022 | ||
| Reema Health is a technology startup transforming how people navigate the gaps between health care and social care. They believe that a personalized, community-based approach to care makes it easy for anyone to access the things they need to make their lives better. | $8M / Seed / Mar 30, 2022 | ||
| Nice Healthcare is revolutionizing comprehensive healthcare for small and medium-sized businesses with technology and in-home care. Their services include in-home and virtual primary care, virtual mental health therapy, and virtual physical therapy. | $30M / Series A / Mar 10, 2022 | ||
| Cíngulo offers emotional well-being through self-knowledge to improve self-esteem, mood, and attitude. | Seed / Mar 09, 2022 | ||
| Anima Educacao also was known as GAEC Educacao SA, is an educational organization group that focuses on secondary education and universities. It also principally engaged in the educational sector.The Company's activities are divided into two segments: Higher education and Vertical management. It was founded on May 6, 2003, and is based inSao Paulo, Brazil. | $178.5M / Post-IPO Equity / Nov 29, 2021 | ||
| Inspirali is an educational institute providing post-graduate training in the health sector. Inspirali provides comprehensive essential knowledge to help individuals develop and qualify their skills so they can become doctors of the future. Inspirali collaborates with partners who share the same vision, and together they move from productdevelopment to technological innovation, always with the goal of empowering future doctors who will democratize access to health. | $178.5M / Secondary Market / Nov 29, 2021 | ||
| See all 43 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does DNA Capital invest in?
DNA Capital invests primarily in Health Care, Medical and Software startups, most often at Seed and Series A stage. Most of the 43 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is DNA Capital's check size?
DNA Capital typically joins rounds of $250k–$8M at Seed, $2M–$30M at Series A and $4.6M–$30M at Series B. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds DNA Capital participates in.
How do I contact DNA Capital?
Public channels for DNA Capital include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at DNA Capital?
The team at DNA Capital includes Carlos de Barros Jorge Neto (Partner), José Guinle (Partner) and Luiz Felipe D Martins Costa (Managing Partner), among 7 team members tracked by Shizune. The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
